Why Exceptional Public Investment in the Development of Vaccines Is Justified for COVID-19, But Not for Other Unmet Medical Needs

Eline M. Bunnik*, Jilles Smids

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

5 Downloads (Pure)
Original languageEnglish
Pages (from-to)22-25
Number of pages4
JournalAmerican Journal of Bioethics
Volume21
Issue number12
DOIs
Publication statusE-pub ahead of print - 22 Nov 2021

Bibliographical note

Funding Information:
The author(s) reported there is no funding associated with the work featured in this article.

Cite this